SEC Form 4 · accession 0001179110-17-011054
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J Starks
Director
Period of report
Aug 2, 2017
Accepted (ET)
Aug 3, 2017 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Aug 2, 2017 | M | 168,413 | $28.50 | A | 6,607,117 | D | |
| Common shares without par value | Aug 2, 2017 | M | 336,131 | $33.14 | A | 6,943,248 | D | |
| Common shares without par valueF1 | holding | — | — | — | 258 | I | Alynne Starks 2012 Irrevocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F2 | $28.50 | Aug 2, 2017 | M | 168,413 | D | Jan 4, 2017 | Jan 3, 2018 | Common shares | 168,413 | 0 | D |
| Option (right to buy)F2 | $33.14 | Aug 2, 2017 | M | 336,131 | D | Jan 4, 2017 | Jan 3, 2018 | Common shares | 336,131 | 0 | D |
Explanation of responses
- F1Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.
- F2St. Jude Medical, Inc. stock option that was converted to an Abbott stock option in connection with Abbott's acquisition of St. Jude Medical, in a transaction exempt from Section 16 under Rule 16b-3.